341 related articles for article (PubMed ID: 26602610)
1. Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
Debernard L; Melzer TR; Alla S; Eagle J; Van Stockum S; Graham C; Osborne JR; Dalrymple-Alford JC; Miller DH; Mason DF
Psychiatry Res; 2015 Dec; 234(3):352-61. PubMed ID: 26602610
[TBL] [Abstract][Full Text] [Related]
2. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
3. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
[TBL] [Abstract][Full Text] [Related]
4. Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center data.
Datta S; Staewen TD; Cofield SS; Cutter GR; Lublin FD; Wolinsky JS; Narayana PA; ;
Mult Scler Relat Disord; 2015 Mar; 4(2):124-36. PubMed ID: 25787188
[TBL] [Abstract][Full Text] [Related]
5. The impact of deep grey matter volume on cognition in multiple sclerosis.
Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
[TBL] [Abstract][Full Text] [Related]
6. Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
Dong X; Xu G; Wang J; Yin N; Meng N
Mult Scler Relat Disord; 2022 Sep; 65():103838. PubMed ID: 35749960
[TBL] [Abstract][Full Text] [Related]
7. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
[TBL] [Abstract][Full Text] [Related]
8. Five year iron changes in relapsing-remitting multiple sclerosis deep gray matter compared to healthy controls.
Elkady AM; Cobzas D; Sun H; Seres P; Blevins G; Wilman AH
Mult Scler Relat Disord; 2019 Aug; 33():107-115. PubMed ID: 31181540
[TBL] [Abstract][Full Text] [Related]
9. Deep gray matter atrophy in multiple sclerosis: a tensor based morphometry.
Tao G; Datta S; He R; Nelson F; Wolinsky JS; Narayana PA
J Neurol Sci; 2009 Jul; 282(1-2):39-46. PubMed ID: 19168189
[TBL] [Abstract][Full Text] [Related]
10. Effect of deep gray matter atrophy on information processing speed in early relapsing-remitting multiple sclerosis.
Naghavi S; Ashtari F; Adibi I; Shaygannejad V; Ramezani N; Pourmohammadi A; Davanian F; Karimi Z; Khaligh-Razavi SM; Sanayei M
Mult Scler Relat Disord; 2023 Mar; 71():104560. PubMed ID: 36806043
[TBL] [Abstract][Full Text] [Related]
11. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.
Bergsland N; Zivadinov R; Dwyer MG; Weinstock-Guttman B; Benedict RH
Mult Scler; 2016 Sep; 22(10):1327-36. PubMed ID: 26541795
[TBL] [Abstract][Full Text] [Related]
12. Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.
Debernard L; Melzer TR; Van Stockum S; Graham C; Wheeler-Kingshott CA; Dalrymple-Alford JC; Miller DH; Mason DF
J Neurol Neurosurg Psychiatry; 2014 May; 85(5):544-51. PubMed ID: 24039024
[TBL] [Abstract][Full Text] [Related]
13. Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume.
Bisecco A; Stamenova S; Caiazzo G; d'Ambrosio A; Sacco R; Docimo R; Esposito S; Cirillo M; Esposito F; Bonavita S; Tedeschi G; Gallo A
Brain Imaging Behav; 2018 Feb; 12(1):20-28. PubMed ID: 28083844
[TBL] [Abstract][Full Text] [Related]
14. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
Wang X; Zhu Q; Yan Z; Shi Z; Xu Y; Liu Y; Li Y
Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
[TBL] [Abstract][Full Text] [Related]
15. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
[TBL] [Abstract][Full Text] [Related]
16. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
[TBL] [Abstract][Full Text] [Related]
17. Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
Du S; Sah SK; Zeng C; Wang J; Liu Y; Xiong H; Li Y
Eur J Radiol; 2015 Jul; 84(7):1325-32. PubMed ID: 25959392
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of single-subject grey matter networks in early multiple sclerosis.
Fleischer V; Gonzalez-Escamilla G; Pareto D; Rovira A; Sastre-Garriga J; Sowa P; Høgestøl EA; Harbo HF; Bellenberg B; Lukas C; Ruggieri S; Gasperini C; Uher T; Vaneckova M; Bittner S; Othman AE; Collorone S; Toosy AT; Meuth SG; Zipp F; Barkhof F; Ciccarelli O; Groppa S
Brain; 2024 Jan; 147(1):135-146. PubMed ID: 37642541
[TBL] [Abstract][Full Text] [Related]
19. Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
Štecková T; Hluštík P; Sládková V; Odstrčil F; Mareš J; Kaňovský P
J Neurol Sci; 2014 Jul; 342(1-2):62-8. PubMed ID: 24819917
[TBL] [Abstract][Full Text] [Related]
20. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
